Literature DB >> 11583950

Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles.

T J Giordano1, K A Shedden, D R Schwartz, R Kuick, J M Taylor, N Lee, D E Misek, J K Greenson, S L Kardia, D G Beer, G Rennert, K R Cho, S B Gruber, E R Fearon, S Hanash.   

Abstract

Molecular classification of tumors based on their gene expression profiles promises to significantly refine diagnosis and management of cancer patients. The establishment of organ-specific gene expression patterns represents a crucial first step in the clinical application of the molecular approach. Here, we report on the gene expression profiles of 154 primary adenocarcinomas of the lung, colon, and ovary. Using high-density oligonucleotide arrays with 7129 gene probe sets, comprehensive gene expression profiles of 57 lung, 51 colon, and 46 ovary adenocarcinomas were generated and subjected to principle component analysis and to a cross-validated prediction analysis using nearest neighbor classification. These statistical analyses resulted in the classification of 152 of 154 of the adenocarcinomas in an organ-specific manner and identified genes expressed in a putative tissue-specific manner for each tumor type. Furthermore, two tumors were identified, one in the colon group and another in the ovarian group, that did not conform to their respective organ-specific cohorts. Investigation of these outlier tumors by immunohistochemical profiling revealed the ovarian tumor was consistent with a metastatic adenocarcinoma of colonic origin and the colonic tumor was a pleomorphic mesenchymal tumor, probably a leiomyosarcoma, rather than an epithelial tumor. Our results demonstrate the ability of gene expression profiles to classify tumors and suggest that determination of organ-specific gene expression profiles will play a significant role in a wide variety of clinical settings, including molecular diagnosis and classification.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11583950      PMCID: PMC1850519          DOI: 10.1016/S0002-9440(10)62509-6

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  15 in total

1.  Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer.

Authors:  J B Welsh; P P Zarrinkar; L M Sapinoso; S G Kern; C A Behling; B J Monk; D J Lockhart; R A Burger; G M Hampton
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

2.  Is TTF1 a good immunohistochemical marker to distinguish primary from metastatic lung adenocarcinomas?

Authors:  J S Reis-Filho; C Carrilho; C Valenti; D Leitão; C A Ribeiro; S G Ribeiro; F C Schmitt
Journal:  Pathol Res Pract       Date:  2000       Impact factor: 3.250

Review 3.  Enzyme immunohistochemistry: technical aspects.

Authors:  K Sheibani; R R Tubbs
Journal:  Semin Diagn Pathol       Date:  1984-11       Impact factor: 3.464

4.  Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung.

Authors:  G Pelosi; F Fraggetta; F Pasini; P Maisonneuve; A Sonzogni; A Iannucci; A Terzi; E Bresaola; F Valduga; C Lupo; G Viale
Journal:  Am J Surg Pathol       Date:  2001-03       Impact factor: 6.394

5.  Molecular classification of cutaneous malignant melanoma by gene expression profiling.

Authors:  M Bittner; P Meltzer; Y Chen; Y Jiang; E Seftor; M Hendrix; M Radmacher; R Simon; Z Yakhini; A Ben-Dor; N Sampas; E Dougherty; E Wang; F Marincola; C Gooden; J Lueders; A Glatfelter; P Pollock; J Carpten; E Gillanders; D Leja; K Dietrich; C Beaudry; M Berens; D Alberts; V Sondak
Journal:  Nature       Date:  2000-08-03       Impact factor: 49.962

6.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.

Authors:  A A Alizadeh; M B Eisen; R E Davis; C Ma; I S Lossos; A Rosenwald; J C Boldrick; H Sabet; T Tran; X Yu; J I Powell; L Yang; G E Marti; T Moore; J Hudson; L Lu; D B Lewis; R Tibshirani; G Sherlock; W C Chan; T C Greiner; D D Weisenburger; J O Armitage; R Warnke; R Levy; W Wilson; M R Grever; J C Byrd; D Botstein; P O Brown; L M Staudt
Journal:  Nature       Date:  2000-02-03       Impact factor: 49.962

7.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring.

Authors:  T R Golub; D K Slonim; P Tamayo; C Huard; M Gaasenbeek; J P Mesirov; H Coller; M L Loh; J R Downing; M A Caligiuri; C D Bloomfield; E S Lander
Journal:  Science       Date:  1999-10-15       Impact factor: 47.728

8.  Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases.

Authors:  P Chu; E Wu; L M Weiss
Journal:  Mod Pathol       Date:  2000-09       Impact factor: 7.842

9.  Intermediate filament proteins and actin isoforms as markers for soft tissue tumor differentiation and origin. II. Rhabdomyosarcomas.

Authors:  O Skalli; G Gabbiani; F Babaï; T A Seemayer; G Pizzolato; W Schürch
Journal:  Am J Pathol       Date:  1988-03       Impact factor: 4.307

10.  Vimentin: an evaluation of its role as a tumour marker.

Authors:  M Leader; M Collins; J Patel; K Henry
Journal:  Histopathology       Date:  1987-01       Impact factor: 5.087

View more
  51 in total

1.  Genome-wide coexpression dynamics: theory and application.

Authors:  Ker-Chau Li
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-16       Impact factor: 11.205

2.  Role of microarray in cancer diagnosis.

Authors:  Hoguen Kim
Journal:  Cancer Res Treat       Date:  2004-02-29       Impact factor: 4.679

3.  Diagnostic molecular pathology: current techniques and clinical applications, part I.

Authors:  George J Netto; Rana D Saad; Peter A Dysert
Journal:  Proc (Bayl Univ Med Cent)       Date:  2003-10

Review 4.  Personalized medicine and development of targeted therapies: The upcoming challenge for diagnostic molecular pathology. A review.

Authors:  Manfred Dietel; Christine Sers
Journal:  Virchows Arch       Date:  2006-04-22       Impact factor: 4.064

5.  Age-related changes in cochlear gene expression in normal and shaker 2 mice.

Authors:  Tzy-Wen L Gong; I Jill Karolyi; James Macdonald; Lisa Beyer; Yehoash Raphael; David C Kohrman; Sally A Camper; Margaret I Lomax
Journal:  J Assoc Res Otolaryngol       Date:  2006-06-23

6.  The search for the primary tumor in metastasized gastroenteropancreatic neuroendocrine neoplasm.

Authors:  D Kaemmerer; N Posorski; F von Eggeling; G Ernst; D Hörsch; R P Baum; V Prasad; R Langer; I Esposito; G Klöppel; S Sehner; T Knösel; M Hommann
Journal:  Clin Exp Metastasis       Date:  2014-08-07       Impact factor: 5.150

7.  Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas.

Authors:  Guoan Chen; Mahaveer S Bhojani; Andrew C Heaford; Daniel C Chang; Bharathi Laxman; Dafydd G Thomas; Laura B Griffin; James Yu; Julia M Coppola; Thomas J Giordano; Lin Lin; David Adams; Mark B Orringer; Brian D Ross; David G Beer; Alnawaz Rehemtulla
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-18       Impact factor: 11.205

8.  Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling.

Authors:  Thomas J Giordano; Rork Kuick; Tobias Else; Paul G Gauger; Michelle Vinco; Juliane Bauersfeld; Donita Sanders; Dafydd G Thomas; Gerard Doherty; Gary Hammer
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

9.  Human papillomavirus is not associated with colorectal cancer in a large international study.

Authors:  Michele C Gornick; Xavier Castellsague; Gloria Sanchez; Thomas J Giordano; Michelle Vinco; Joel K Greenson; Gabriel Capella; Leon Raskin; Gad Rennert; Stephen B Gruber; Victor Moreno
Journal:  Cancer Causes Control       Date:  2010-01-20       Impact factor: 2.506

10.  Profiling of pathway-specific changes in gene expression following growth of human cancer cell lines transplanted into mice.

Authors:  Chad Creighton; Rork Kuick; David E Misek; David S Rickman; Franck M Brichory; Jean-Marie Rouillard; Gilbert S Omenn; Samir Hanash
Journal:  Genome Biol       Date:  2003-06-23       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.